s6y

SpyGlass Pharma, Inc.

Ticker
SGP
CIK
1778922
Industry
Surgical & Medical Instruments & Apparatus
Formerly
SpyGlassPharma, Inc., SpyGlass Ophthalmics, Inc.

Financials 4

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025

News 9

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing

Ownership 56

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4/A Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 56 ownership filings

Prospectus 7

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  3. S-1/A General form of registration statement for all companies including face-amount certificate companies
  4. S-1 General form of registration statement for all companies including face-amount certificate companies
  5. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  6. DRSLTR Correspondence Related to Draft Registration Statement
  7. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Other 22

  1. 144 Filing for proposed sale of securities under Rule 144
  2. SCHEDULE 13D/A
  3. SCHEDULE 13G
  4. SCHEDULE 13D
  5. SCHEDULE 13G
  6. SCHEDULE 13D
  7. SCHEDULE 13D
  8. SCHEDULE 13D
  9. 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
  10. CERT Certification by an exchange approving securities for listing

All 22 other filings